| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 178 | 100.0% | 0.30 | 219 | 99.5% |
| CentralBrain-unspecified | 0 | 0.0% | inf | 1 | 0.5% |
| upstream partner | # | NT | conns HRN_VP1l | % In | CV |
|---|---|---|---|---|---|
| lLN2F_a (L) | 2 | unc | 13 | 24.5% | 0.1 |
| lLN2X12 (L) | 6 | ACh | 7 | 13.2% | 0.4 |
| lLN2F_b (L) | 2 | GABA | 6.5 | 12.3% | 0.2 |
| lLN2X11 (L) | 2 | ACh | 6 | 11.3% | 0.0 |
| lLN2R_a (L) | 2 | GABA | 5 | 9.4% | 0.0 |
| lLN1_bc (L) | 6 | ACh | 3.5 | 6.6% | 0.3 |
| HRN_VP1d | 3 | ACh | 2.5 | 4.7% | 0.6 |
| lLN2X05 (L) | 2 | ACh | 2 | 3.8% | 0.5 |
| OA-VUMa2 (M) | 1 | OA | 1 | 1.9% | 0.0 |
| HRN_VP1l | 1 | ACh | 1 | 1.9% | 0.0 |
| HRN_VP5 | 2 | ACh | 1 | 1.9% | 0.0 |
| v2LN41 (L) | 2 | unc | 1 | 1.9% | 0.0 |
| HRN_VP4 | 1 | ACh | 0.5 | 0.9% | 0.0 |
| lLN2T_a (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| lLN2T_e (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| v2LN34F (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| lLN2P_b (L) | 1 | GABA | 0.5 | 0.9% | 0.0 |
| lLN2T_b (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 0.5 | 0.9% | 0.0 |
| downstream partner | # | NT | conns HRN_VP1l | % Out | CV |
|---|---|---|---|---|---|
| lLN2F_a (L) | 2 | unc | 32.5 | 11.8% | 0.2 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 27.5 | 10.0% | 0.0 |
| VP1l+_lvPN (L) | 4 | ACh | 27 | 9.8% | 0.2 |
| lLN2X12 (L) | 6 | ACh | 20.5 | 7.4% | 0.3 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 17.5 | 6.4% | 0.0 |
| lLN2X11 (L) | 2 | ACh | 17.5 | 6.4% | 0.1 |
| lLN2F_b (L) | 2 | GABA | 14.5 | 5.3% | 0.2 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 13.5 | 4.9% | 0.0 |
| lLN2R_a (L) | 3 | GABA | 10.5 | 3.8% | 0.6 |
| M_lvPNm35 (L) | 2 | ACh | 8.5 | 3.1% | 0.9 |
| CB1545 (L) | 1 | Glu | 7 | 2.5% | 0.0 |
| lLN1_bc (L) | 6 | ACh | 7 | 2.5% | 0.3 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 6.5 | 2.4% | 0.0 |
| CB3417 (L) | 2 | unc | 5.5 | 2.0% | 0.5 |
| lLN2P_b (L) | 2 | GABA | 5 | 1.8% | 0.4 |
| HRN_VP1d | 5 | ACh | 5 | 1.8% | 0.5 |
| lLN2X05 (L) | 2 | ACh | 4.5 | 1.6% | 0.6 |
| lLN2X04 (L) | 2 | ACh | 4.5 | 1.6% | 0.1 |
| lLN1_a (L) | 1 | ACh | 4 | 1.5% | 0.0 |
| v2LN41 (L) | 2 | unc | 4 | 1.5% | 0.5 |
| VP1d+VP4_l2PN1 (R) | 1 | ACh | 3 | 1.1% | 0.0 |
| lLN2T_a (L) | 3 | ACh | 3 | 1.1% | 0.4 |
| v2LN34A (L) | 2 | Glu | 2 | 0.7% | 0.0 |
| v2LN41 (R) | 1 | unc | 1.5 | 0.5% | 0.0 |
| v2LN3A (L) | 1 | unc | 1.5 | 0.5% | 0.0 |
| M_smPN6t2 (R) | 1 | GABA | 1.5 | 0.5% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 1.5 | 0.5% | 0.0 |
| HRN_VP1l | 1 | ACh | 1 | 0.4% | 0.0 |
| CB3007 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| M_lPNm11B (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.4% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1048 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| v2LN49 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| VP1d+VP4_l2PN2 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| TRN_VP1m | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB3383 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN2P_a (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| vLN24 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| M_l2PNm17 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| M_l2PN3t18 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| ALIN4 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| ALIN5 (R) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| v2LN34E (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| v2LN34B (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| CB4083 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| M_vPNml60 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| v2LN38 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| VP3+_vPN (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| M_lvPNm37 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| M_ilPNm90 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| M_smPNm1 (R) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| lLN2T_b (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| M_l2PNm14 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN2T_e (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
